Crossmark

A new dawn in neurodegeneration research: MN advances

Crossref DOI link: https://doi.org/10.1186/s44477-025-00001-0

Published Online: 2025-04-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bu, Guojun
License Information

Text and Data Mining valid from 2025-04-11

Version of Record valid from 2025-04-11
More Information

Article History

First Online: 11 April 2025

Declarations

:

: G.B. consults for SciNeuro Pharmaceuticals and Kisbee Therapeutics.